Cardiovascular Research

Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events.

Authors: Graham Jackson|||Robert A Kloner|||Timothy M Costigan|||Margaret R Warner|||Jeffrey T Emmick

Affiliations: + Expand

Abstract

Cardiovascular disease and erectile dysfunction (ED) share similar risk factors and often occur concomitantly. Therefore, men with ED may be at increased risk for cardiovascular adverse events.

---

Chemical List

Carbolines|||Phosphodiesterase Inhibitors|||Tadalafil